Health insurers led U.S. stocks lower as investors fled the sector plagued by increasing political risks from Washington.
Technology and biotech shares led U.S. stocks lower as major averages gave up modest gains. Treasuries slipped.
Federal Reserve policy makers last month grappled with “significant uncertainties” and persistently low inflation as they scrapped forecasts for interest-rate hikes in 2019 even while voicing the need to maintain policy flexibility.
What’s the best recipe for making money after a huge global equities rally? One bet is to ignore the lures of a herd mentality.
Stocks fell and Treasuries rose amid renewed concerns about slowing global growth and an escalation of trade tensions. Oil edged lower.
It’s going to take a lot to dispel the bond market’s view that the world’s biggest economy needs stimulus, but some consistent signals on inflation would help.
Marko Kolanovic is blaming a “negative feedback loop between volatility and liquidity” for topsy-turvy markets.
The bond market remains confident after the latest U.S. jobs data that the Federal Reserve’s next move will likely be to lower rates. But traders are scratching their heads when it comes to President Donald Trump’s suggestion that policy makers should restore quantitative easing.
U.S. hiring rebounded more than forecast in March and the prior month was stronger than first reported, potentially relieving some concerns about a cooling economy. Wage gains eased and the unemployment rate held near a 49-year low.
Federal Reserve officials said they were comfortable with keeping interest rates on hold as they assess whether recent economic weakness is temporary or lasting, with one normally more hawkish policy maker suggesting the hiking cycle may now be over.
Investors are yanking money out of gold exchange-traded funds as hints of improving global growth and surging stocks lure them into riskier assets.